News: Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

97.50EUR
23 Jan 2015
Change (% chg)

€1.41 (+1.47%)
Prev Close
€96.09
Open
€96.50
Day's High
€98.43
Day's Low
€96.50
Volume
33,278
Avg. Vol
27,606
52-wk High
€98.43
52-wk Low
€74.25

Search Stocks
Select another date:

Thu, Jan 22 2015

BRIEF-Biomerieux and Astute Medical to develop and market Nephrocheck test

* Biomerieux and Astute Medical sign a global agreement to develop and market Nephrocheck test for Vidas, an assay to assess the risk of developing acute kidney injury

BRIEF-Biomerieux FY revenue rises to 1.7 billion euros

* FY revenue 1.7 billion euros versus 1.59 billion euros last year

BRIEF-Biomerieux signs strategic alliance with Copan

* Strategic alliance signed between Biomérieux and Copan to automate clinical microbiology laboratories and enhance their operational efficiency

BRIEF-Biomerieux agrees with Illumina to launch NGS epidemiology solution for service labs

* Signs exclusive agreement with Illumina to launch a next-generation sequencing (NGS) epidemiology solution for service labs

BRIEF-Biomerieux gets FDA fast-track authorization of Ebola test

* Says its Biofire Defense unit receives fast-track authorization of FilmArray Ebola test

BRIEF-Biomerieux Q3 revenue rises to 412.0 million euros

* Q3 revenue 412.0 million euros versus 390 million euros last year

BioMerieux working to get FDA approval for Ebola screening test

- BioMerieux SA is working with U.S. health regulators to determine if its test to screen for bio threats could be used to detect the Ebola virus, spokeswoman Suzanne Jones said.

BioMerieux working to get FDA approval for Ebola screening test

Oct 20 - BioMerieux SA is working with U.S. health regulators to determine if its test to screen for bio threats could be used to detect the Ebola virus, spokeswoman Suzanne Jones said.

BRIEF-Biomerieux reports lower H1 operating income

* H1 contributive operating income before non-recurring items 94 million euros versus 125 million euros in H1 2013

Select another date:
Search Stocks